欧洲抗风湿病联盟关于银屑病关节炎药物治疗十项建议.pdf

Res Ther, 2004, 6: 86-89. @@[4] Menard HA, Lapointe E, Rochdi M, et al. Insights into rheuma toid arthritis derived from the Sa immune sytem. Arthritis Res, 2000, 2: 429-432. @@[5] Gilles B, Pierre C, Artur J, et al. Anti-Sa antibodies and anti bodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset pol yarthritis. Arthritis Res, 2005, 7: 592-603. @@[6] Egerer K, Feist E, Burmester GR. The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens. Dtsch Arztebl Int, 2009, 106: 159-163. @@[7] Vossenaar ER, Despres N, Lapointe E, et al. Rheumatoid arthri tis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther, 2004, 6: 142-150. @@[8] Alaniz RC, Sandall S, Thomas EK, et al. Increased dendritic cell numbers impair protective immunity to intracellular bacteria despite augmenting antigen-specific CD8+T lymphoeyte respons es. J Immunol, 2004, 172: 3725-3735. @@ [9] Byun Y, Chen F, Chang R, et al. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptesis. Cell Death Differ, 2001, 8: 443-450. @@[10] Yang XW, Wang JH, Liu CR, et al. Cleavage of p53 vimentin complex enhances tumor necrosis factor-related apoptosis of rheumatoid arthritis synovial fibroblasts. Am J Pathol, 2005, 167: 705-719. @@[11] Hill JA, Southwood S, Sette A, et al. Cutting edge: the conver sion of arginine to citrullline allows for a high-affinity peptide interaction with the rheumatoid arthritis associated HLA-DRB1 * 0401 MHC class ¢ò molecule. J Immunol, 2003, 171 : 538-541. @@[12] Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PAD14, encoding citrullinating enzyme peptidelarginine deimi nase 4, are associated with rheumatoid arthritis. Nat Genet, 2003, 34: 395-402. 2011-01-27 ŷÖ